
Among 821,327 outpatients, cystatin C–based eGFR at least 30% below creatinine-based eGFR was linked to higher death and heart failure rates.
Supplements and Featured Publications
over 28 years ago
Participating Facultyover 28 years ago
Introduction: Treatment of Heart Failure: A Managed Care Perspectiveover 28 years ago
Epidemiology, Prevalence, Treatments, and Clinical Trialsover 28 years ago
Clinical Practice Guidelines for Heart Failureover 28 years ago
Cost of Heart Failure to the Healthcare Systemover 28 years ago
Selected Abstractsover 28 years ago
CME Quizover 28 years ago
Bibliography





